Consumer Recalls Daily2026-10-18October 18, 2026
Oct 18 Recall Digest — 10 FDA Drug Recalls (CPSC Feed Down)
// Summary
CPSC's consumer product recall feed failed to return data this run and is flagged for follow-up. FDA drug recalls dominate today's log with ten actions spanning sterility failures, dissolution and potency defects, a temperature excursion, and a packaging defect — none report associated injuries or deaths.
| Total | 11 (1 CPSC source error, 10 FDA) |
| CPSC items | 0 (source unavailable) |
| FDA items | 10 |
| Class I | 0 |
| Class II | 9 |
| Not Yet Classified | 1 |
// CPSC — Consumer Products
Source unavailable
| Agency | CPSC |
| Status | FETCH FAILED |
| Reason | Provider error on Open; no recall data retrieved this run. |
No CPSC consumer-product recalls to report today. Will re-pull next cycle.
// FDA — Sterility & Contamination
Benzoyl Peroxide Wash 10%
| ID | D-0879-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Benzoyl Peroxide Wash USP 10%, 5 FL OZ (NDC 0536-1261-63) and 8.5 FL OZ (NDC 0536-1351-42) |
| Manufacturer | SV Labs Toronto Corporation; distributed by Rugby Laboratories, Livonia, MI |
| Reason | Microbial contamination of topical product |
| Lot/Exp | 0575-01-366 (Jan-27), 0565-02-336 (Feb-27), 0645-02-355, 0575-02-336 (Feb-27), 0565-12-317 (Dec-26) |
| Location | IL only |
| Filed | 2026-10-07 |
Benzoyl Peroxide Wash 5%
| ID | D-0878-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Benzoyl Peroxide Wash USP 5%, 5 FL OZ, NDC 0536-1259-63 |
| Manufacturer | SV Labs Toronto Corporation; distributed by Rugby Laboratories, Livonia, MI |
| Reason | Microbial contamination of topical product |
| Lot/Exp | 0525-02-345, Exp 02/2027 |
| Location | IL only |
| Filed | 2026-10-07 |
Same manufacturer, same root cause — both Rugby-labeled wash products from SV Labs Toronto are contamination holds limited to Illinois distribution; firms using this supplier should check stock broadly.
FOCUS PI Hypromellose 0.7% Formula
| ID | D-0874-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Sterile hypromellose 0.7% formula, 10 mL vial, NDC 82724-007-19 |
| Manufacturer | Aurolab Trust (India); for Covalent Management, Inc., Manassas, VA |
| Reason | Lack of assurance of sterility |
| Lot/Exp | 6B093FI (04/01/28), 6F511F1 (05/15/28) |
| Location | VA |
| Filed | 2026-10-07 |
TRP Gentle Eyes Lubricant Eye Drops
| ID | D-0860-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Carboxymethylcellulose sodium 0.5% sterile eye drops, 0.5 FL OZ, NDC 17312-430-15 |
| Manufacturer | Sterling Pharmaceutical Services LLC; for TRP Company, Inc., Reno, NV |
| Reason | Lack of assurance of sterility |
| Lot/Exp | 3279 (6/30/27), 3292 (5/31/27) |
| Location | USA Nationwide |
| Filed | 2026-09-30 |
// FDA — Quality & Specification Failures
Paroxetine Extended-Release Tablets
| ID | D-0877-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Paroxetine ER 37.5mg, 30-count, NDC 60505-1318-3 |
| Manufacturer | Apotex Inc. (Toronto) for Apotex Corp., Weston, FL |
| Reason | Failed dissolution specifications |
| Lot/Exp | TY9495, 05/2027 |
| Location | US Nationwide |
| Filed | 2026-10-07 |
Ranolazine Extended-Release Tablets
| ID | D-0010-2027 |
| Class | Class II |
| Status | Ongoing |
| Product | Ranolazine ER 1000mg, 60-count, NDC 27241-126-02 |
| Manufacturer | Ajanta Pharma USA Inc., Bridgewater, NJ |
| Reason | Failed dissolution specifications (below spec) |
| Lot/Exp | DJ25134, 11/30/2028 |
| Location | US Nationwide |
| Filed | 2026-10-07 |
Buprenorphine Hydrochloride Injection
| ID | D-0876-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Buprenorphine HCl Injection 0.3 mg/mL, 5x1mL single-dose vials, NDC 42023-179-05 |
| Manufacturer | Par Health USA, LLC; for Endo USA, Malvern, PA |
| Reason | Crystallization |
| Lot/Exp | 83912 (10/26), 84234 (11/26), 84990 (11/26), 85003 (12/26), 86443 (01/27), 89909 (05/27) |
| Location | US Nationwide |
| Filed | 2026-10-07 |
Six lots of injectable buprenorphine recalled for crystallization — a visible-particulate risk for a controlled-substance injectable; pharmacies should inspect vials before dispensing.
Amazon Acetaminophen Extra Strength Caplets
| Class | Not Yet Classified |
| Status | Ongoing |
| Product | Acetaminophen 500mg caplets, 1000-count bottle, NDC 72288-692-01 |
| Manufacturer | Aurobindo Pharma USA Inc.; distributed by Amazon.com Services LLC |
| Reason | Discoloration — consumer complaints of discolored tablets |
| Lot/Exp | ACD124048A, 11/30/2027 |
| Location | US Nationwide |
| Filed | 2026-10-07 |
Estradiol Gel
| ID | D-0873-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Estradiol Gel 0.1% (0.25mg), 30-packet carton, NDC 69238-2452-3 |
| Manufacturer | Amneal Pharmaceuticals LLC, Bridgewater, NJ |
| Reason | Defective container — packets found empty or partially full |
| Lot/Exp | 245226005B, 04/30/2028 |
| Location | US Nationwide |
| Filed | 2026-10-07 |
// FDA — Distribution / Storage Excursion
Zoladex (goserelin) Implant
| ID | D-0875-2026 |
| Class | Class II |
| Status | Ongoing |
| Product | Goserelin 3.6mg single-use syringe implant, NDC 70720-950-36 |
| Manufacturer | TerSera Therapeutics LLC; mfd by AstraZeneca UK Ltd (Switzerland) |
| Reason | Temperature abuse — product sat in non-temperature-controlled FedEx trailer ~25.5 hours |
| Lot/Exp | YN0099, 01/31/2028 |
| Location | USA Nationwide |
| Filed | 2026-10-07 |
A single-lot excursion for an oncology/endocrine implant drug; efficacy risk warrants provider-level lot checks before administration.